277 related articles for article (PubMed ID: 12640661)
1. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
3. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer expression profiling by cDNA sequencing analysis.
Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP.
Goodin JL; Rutherford CL
Mol Carcinog; 2002 Feb; 33(2):88-98. PubMed ID: 11813301
[TBL] [Abstract][Full Text] [Related]
6. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T
Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
Ellis WJ; Vessella RL; Buhler KR; Bladou F; True LD; Bigler SA; Curtis D; Lange PH
Clin Cancer Res; 1996 Jun; 2(6):1039-48. PubMed ID: 9816265
[TBL] [Abstract][Full Text] [Related]
8. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
[TBL] [Abstract][Full Text] [Related]
9. Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model.
Uchida K; Masumori N; Takahashi A; Itoh N; Tsukamoto T
Prostate; 2005 Jan; 62(1):40-8. PubMed ID: 15389815
[TBL] [Abstract][Full Text] [Related]
10. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer.
Glinsky GV; Krones-Herzig A; Glinskii AB; Gebauer G
Mol Carcinog; 2003 Aug; 37(4):209-21. PubMed ID: 12891630
[TBL] [Abstract][Full Text] [Related]
12. LuCaP 35: a new model of prostate cancer progression to androgen independence.
Corey E; Quinn JE; Buhler KR; Nelson PS; Macoska JA; True LD; Vessella RL
Prostate; 2003 Jun; 55(4):239-46. PubMed ID: 12712403
[TBL] [Abstract][Full Text] [Related]
13. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.
Pinthus JH; Waks T; Schindler DG; Harmelin A; Said JW; Belldegrun A; Ramon J; Eshhar Z
Cancer Res; 2000 Dec; 60(23):6563-7. PubMed ID: 11118033
[TBL] [Abstract][Full Text] [Related]
14. Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
Agemy L; Harmelin A; Waks T; Leibovitch I; Rabin T; Pfeffer MR; Eshhar Z
Prostate; 2008 Apr; 68(5):530-9. PubMed ID: 18247403
[TBL] [Abstract][Full Text] [Related]
15. Development of a prostate cDNA microarray and statistical gene expression analysis package.
Carlisle AJ; Prabhu VV; Elkahloun A; Hudson J; Trent JM; Linehan WM; Williams ED; Emmert-Buck MR; Liotta LA; Munson PJ; Krizman DB
Mol Carcinog; 2000 May; 28(1):12-22. PubMed ID: 10820484
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer.
Waghray A; Schober M; Feroze F; Yao F; Virgin J; Chen YQ
Cancer Res; 2001 May; 61(10):4283-6. PubMed ID: 11358857
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
19. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
